Basic Principles of Antisense Therapeutics
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- DNA antisense therapy for asthma in an animal modelNature, 1997
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Oligonucleotide duplex stability controlled by the 7-substituents of 7-deazaguanine basesBioorganic & Medicinal Chemistry Letters, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genesKidney International, 1994
- Modulation of substance P/neurokinin-1 receptor in human astrocytoma cells by antisense oligodeoxynucleotidesGeneral Pharmacology: The Vascular System, 1994
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994
- Antisense oligonucleotides made of 2'‐O‐alkylRNA: their properties and applications in RNA biochemistryFEBS Letters, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992